Myeloid TAKI [corrected] acts as a negative regulator of the LPS response and mediates resistance to endotoxemia

PLoS One. 2012;7(2):e31550. doi: 10.1371/journal.pone.0031550. Epub 2012 Feb 14.

Abstract

TGFβ-activated kinase 1 (TAK1), a member of the mitogen-activated protein kinase kinase kinase (MAP3K) family, is considered a key intermediate in a multitude of innate immune signaling pathways. Yet, the specific role of TAK1 in the myeloid compartment during inflammatory challenges has not been revealed. To address this question, we generated myeloid-specific kinase-dead TAK1 mutant mice. TAK1 deficiency in macrophages results in impaired NF-κB and JNK activation upon stimulation with lipopolysaccharide (LPS). Moreover, TAK1-deficient macrophages and neutrophils show an enhanced inflammatory cytokine profile in response to LPS stimulation. Myeloid-specific TAK1 deficiency in mice leads to increased levels of circulating IL-1β, TNF and reduced IL-10 after LPS challenge and sensitizes them to LPS-induced endotoxemia. These results highlight an antiinflammatory role for myeloid TAK1, which is essential for balanced innate immune responses and host survival during endotoxemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cytokines / blood
  • Endotoxemia / immunology*
  • Immunity, Innate
  • JNK Mitogen-Activated Protein Kinases
  • Lipopolysaccharides / antagonists & inhibitors
  • Lipopolysaccharides / pharmacology*
  • MAP Kinase Kinase Kinases / deficiency
  • MAP Kinase Kinase Kinases / immunology*
  • Macrophages / immunology*
  • Mice
  • Mice, Knockout
  • NF-kappa B
  • Neutrophils / immunology

Substances

  • Cytokines
  • Lipopolysaccharides
  • NF-kappa B
  • JNK Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase Kinases
  • MAP kinase kinase kinase 7